Compass to Present at 17th Annual Needham Technology & Media Conference
Get Alerts COMP Hot Sheet
Join SI Premium – FREE
NEW YORK, May 11, 2022 /PRNewswire/ -- Compass, Inc. (NYSE: COMP), a leading technology-enabled residential real estate brokerage, today announced that management will present at the 17th Annual Needham Technology & Media Conference on Monday May 16, 2022. The virtual Fireside Chat is scheduled to begin at 2:15 p.m. ET.
Both live and replay versions of the presentation will be available under the Events & Presentations section on the Compass Investor Relations website, https://investors.compass.com.
About Compass
Founded in 2012, Compass is the largest residential real estate brokerage in the United States.1 The technology-enabled brokerage provides an end-to-end platform that empowers its residential real estate agents to deliver exceptional service to seller and buyer clients. The platform includes an integrated suite of cloud-based software for customer relationship management, marketing, client service, brokerage services and other critical functionality, all custom-built for the real estate industry. Compass agents utilize the platform to grow their business, save time and manage their business more effectively. For more information on how Compass empowers real estate agents, one of the largest groups of small business owners in the country, please visit www.Compass.com.
1 T. Velt, "RealTrends 500: The Rise of Compass," RealTrends, Online, HW Media, 3/25/2022, https://www.realtrends.com/realtrends-500-the-rise-of-compass/.
View original content to download multimedia:https://www.prnewswire.com/news-releases/compass-to-present-at-17th-annual-needham-technology--media-conference-301545488.html
SOURCE Compass
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- OpenText to Create 400 Jobs with €105 Million Investment in Cork and Galway to Expand Agentic AI and Sovereign Cloud in Europe
- Luxel Corporation Appoints KOS, Inc. as Exclusive Distributor in South Korea
- Press Release: Sanofi’s Tzield approved in the US as the first disease-modifying therapy for patients recently diagnosed with stage 3 type 1 diabetes
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Needham & CompanySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share